902
Participants
Start Date
June 4, 2018
Primary Completion Date
February 22, 2020
Study Completion Date
March 20, 2020
Semaglutide
Subcutaneous (under the skin) injection of semaglutide once-weekly.
Placebo
Subcutaneous (under the skin) injection of semaglutide placebo once-weekly.
Novo Nordisk Investigational Site, Geneva
Novo Nordisk Investigational Site, Frederiksberg C
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Durban
Novo Nordisk Investigational Site, Køge
Novo Nordisk Investigational Site, Olten
Novo Nordisk Investigational Site, Zurich
Novo Nordisk Investigational Site, Zollikerberg
Novo Nordisk Investigational Site, Sankt Gallen
Novo Nordisk Investigational Site, Sankt Gallen
Novo Nordisk Investigational Site, New York
Novo Nordisk Investigational Site, Arlington
Novo Nordisk Investigational Site, Richmond
Novo Nordisk Investigational Site, Greensboro
Novo Nordisk Investigational Site, Raleigh
Novo Nordisk Investigational Site, Greenville
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Salisbury
Novo Nordisk Investigational Site, Alpharetta
Novo Nordisk Investigational Site, Suwanee
Novo Nordisk Investigational Site, Roswell
Novo Nordisk Investigational Site, Haifa
Novo Nordisk Investigational Site, Anniston
Novo Nordisk Investigational Site, Chattanooga
Novo Nordisk Investigational Site, Bristol
Novo Nordisk Investigational Site, Louisville
Novo Nordisk Investigational Site, Seville
Novo Nordisk Investigational Site, Seville
Novo Nordisk Investigational Site, Seville
Novo Nordisk Investigational Site, Kfar Saba
Novo Nordisk Investigational Site, Cincinnati
Novo Nordisk Investigational Site, Dayton
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Buckley
Novo Nordisk Investigational Site, Tel Litwinsky
Novo Nordisk Investigational Site, Kharkiv
Novo Nordisk Investigational Site, Tel Aviv
Novo Nordisk Investigational Site, Odesa
Novo Nordisk Investigational Site, Baton Rouge
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Austin
Novo Nordisk Investigational Site, Jerusalem
Novo Nordisk Investigational Site, San Diego
Novo Nordisk Investigational Site, Fresno
Novo Nordisk Investigational Site, Elkridge
Novo Nordisk Investigational Site, Omaha
Novo Nordisk Investigational Site, Bristol
Novo Nordisk Investigational Site, Wenatchee
Novo Nordisk Investigational Site, Amsterdam
Novo Nordisk Investigational Site, Amsterdam
Novo Nordisk Investigational Site, Arnhem
Novo Nordisk Investigational Site, Braga
Novo Nordisk Investigational Site, Coimbra
Novo Nordisk Investigational Site, Matosinhos Municipality
Novo Nordisk Investigational Site, Porto
Novo Nordisk Investigational Site, Porto
Novo Nordisk Investigational Site, Vila Nova de Gaia
Novo Nordisk Investigational Site, Pretoria
Novo Nordisk Investigational Site, Pretoria
Novo Nordisk Investigational Site, Brits
Novo Nordisk Investigational Site, Almería
Novo Nordisk Investigational Site, Sabadell
Novo Nordisk Investigational Site, Malmo
Novo Nordisk Investigational Site, Stockholm
Novo Nordisk Investigational Site, Uppsala
Novo Nordisk Investigational Site, Kyiv
Novo Nordisk Investigational Site, Kyiv
Novo Nordisk Investigational Site, Kyiv
Lead Sponsor
Novo Nordisk A/S
INDUSTRY